• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期帕金森病患者十二指肠给予左多巴/卡比多巴输注治疗可改善照料者的压力和负担。

Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden.

机构信息

Section of Neurology, Hospital A. Marcide, Ferrol, Spain.

出版信息

Eur J Neurol. 2012 Sep;19(9):1261-5. doi: 10.1111/j.1468-1331.2011.03630.x. Epub 2012 Jan 17.

DOI:10.1111/j.1468-1331.2011.03630.x
PMID:22248261
Abstract

BACKGROUND

Continuous duodenal levodopa infusion (DLI) is an effective therapy that improves quality of life (QoL) in advanced Parkinson's disease (PD). However, the impact of DLI on caregivers' stress and burden has not been reported.

METHODS

We evaluated prospectively open-label seven advanced PD patients (65.7 ± 9.6 years, 71.4% men) treated with DLI. Schwab & England Activities of Daily Living Scale (ADLS), 39-item Parkinson's disease QoL Questionnaire Summary Index score (PDQ-39SI), Zarit Caregiver Burden Interview (ZCBI), and Caregiver Strain Index (CSI) were used. Comparisons were made between scores obtained at baseline and those at a mean follow-up of 31.4 ± 7.9 months (range, 23-42).

RESULTS

In patients, mean ± SD ADLS was increased from 50 ± 8.2 to 80 ± 11.6 (P = 0.014), and mean ± SD PDQ-39SI was decreased from 53.7 ± 11.9 to 33.6 ± 12.8 (P = 0.018). In caregivers, ZCBI decreased from 43 ± 13.3 to 20.7 ± 12.1 (P = 0.018) and CSI from 6.3 ± 2.5 to 1.6 ± 0.9 (P = 0.018). At baseline, 57.1% of caregivers reported moderate to severe burden (ZCBI 41-88) compared to 28.6% at the end of the follow-up (P = 0.015); at that time, no caregiver reported high level of stress (CSI ≥ 7) compared to 57.1% at baseline (P = 0.046). There were significant correlations between ZCBI and CSI improvement (r = 0.813, P = 0.026), ZCBI and PDQ-39SI (r = 0.875, P = 0.01), and ZCBI and ADLS (r = 0.813, P = 0.026).

CONCLUSIONS

Duodenal levodopa infusion-related clinical improvement in patients with advanced PD leads to substantial reductions in caregivers' stress and burden.

摘要

背景

连续十二指肠左旋多巴输注(DLI)是一种有效的治疗方法,可改善晚期帕金森病(PD)患者的生活质量(QoL)。然而,DLI 对照顾者的压力和负担的影响尚未报道。

方法

我们前瞻性地评估了 7 名接受 DLI 治疗的晚期 PD 患者(65.7 ± 9.6 岁,71.4%为男性)。使用 Schwab & England 日常生活活动量表(ADLS)、39 项帕金森病生活质量问卷综合指数评分(PDQ-39SI)、Zarit 照顾者负担量表(ZCBI)和照顾者压力指数(CSI)进行评估。比较了基线时和平均随访 31.4 ± 7.9 个月(范围 23-42 个月)时的评分。

结果

患者的平均 ± SD ADLS 从 50 ± 8.2 增加到 80 ± 11.6(P = 0.014),平均 ± SD PDQ-39SI 从 53.7 ± 11.9 降低至 33.6 ± 12.8(P = 0.018)。在照顾者中,ZCBI 从 43 ± 13.3 降至 20.7 ± 12.1(P = 0.018),CSI 从 6.3 ± 2.5 降至 1.6 ± 0.9(P = 0.018)。基线时,57.1%的照顾者报告有中度至重度负担(ZCBI 41-88),而随访结束时这一比例为 28.6%(P = 0.015);此时,没有照顾者报告有高度压力(CSI ≥ 7),而基线时这一比例为 57.1%(P = 0.046)。ZCBI 和 CSI 改善之间存在显著相关性(r = 0.813,P = 0.026),ZCBI 和 PDQ-39SI 之间存在显著相关性(r = 0.875,P = 0.01),ZCBI 和 ADLS 之间存在显著相关性(r = 0.813,P = 0.026)。

结论

晚期 PD 患者接受 DLI 治疗后临床状况改善,可显著降低照顾者的压力和负担。

相似文献

1
Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden.晚期帕金森病患者十二指肠给予左多巴/卡比多巴输注治疗可改善照料者的压力和负担。
Eur J Neurol. 2012 Sep;19(9):1261-5. doi: 10.1111/j.1468-1331.2011.03630.x. Epub 2012 Jan 17.
2
Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being.长期接受十二指肠左旋多巴/卡比多巴输注治疗可改善生活质量,特别是与移动能力、日常生活活动和情绪健康有关。
Acta Neurol Scand. 2012 Mar;125(3):187-91. doi: 10.1111/j.1600-0404.2011.01523.x. Epub 2011 May 26.
3
Factors contributing to caregivers' stress and burden in Parkinson's disease.帕金森病中导致照料者压力和负担的因素。
Acta Neurol Scand. 2015 Apr;131(4):203-10. doi: 10.1111/ane.12305. Epub 2014 Sep 12.
4
Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study.晚期帕金森病患者的照顾者负担及其相关因素:来自 PREDICT 研究的数据。
J Neurol. 2018 May;265(5):1124-1137. doi: 10.1007/s00415-018-8816-9. Epub 2018 Mar 7.
5
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.晚期帕金森病患者的空肠内左旋多巴输注:对运动和非运动症状的长期影响及其对患者和照料者生活质量的影响。
Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):79-89.
6
Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.改善晚期帕金森病患者应用左旋多巴-卡比多巴肠凝胶治疗相关的冲动控制障碍。
J Neurol. 2018 Jun;265(6):1279-1287. doi: 10.1007/s00415-018-8803-1. Epub 2018 Mar 20.
7
Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's disease with end-of-dose wearing off.即刻与延迟转换左旋多巴/卡比多巴为左旋多巴/卡比多巴/恩他卡朋:对伴有剂末现象的帕金森病患者运动功能和生活质量的影响。
Int J Neurosci. 2011 Nov;121(11):605-13. doi: 10.3109/00207454.2011.598982. Epub 2011 Aug 16.
8
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.晚期帕金森病中十二指肠左旋多巴输注单一疗法与口服多种药物联合治疗的比较
Neurology. 2005 Jan 25;64(2):216-23. doi: 10.1212/01.WNL.0000149637.70961.4C.
9
Assessment of Duodopa effects on quality of life of patients with advanced Parkinson's disease and their caregivers.评估 Duodopa 对晚期帕金森病患者及其照护者生活质量的影响。
J Neurol. 2018 Sep;265(9):2005-2014. doi: 10.1007/s00415-018-8951-3. Epub 2018 Jun 27.
10
Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.左旋多巴/卡比多巴肠凝胶治疗晚期帕金森病患者的运动和非运动结果:GREENFIELD 观察性研究的最终结果。
J Neurol. 2019 Sep;266(9):2164-2176. doi: 10.1007/s00415-019-09337-6. Epub 2019 May 27.

引用本文的文献

1
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden.根据 MNCD 分类对帕金森病进行分期与照料者负担相关。
Brain Behav. 2023 Dec;13(12):e3295. doi: 10.1002/brb3.3295. Epub 2023 Nov 8.
2
A single centre prospective study of three device-assisted therapies for Parkinson's disease.一项针对帕金森病三种器械辅助治疗的单中心前瞻性研究。
NPJ Parkinsons Dis. 2023 Jun 29;9(1):101. doi: 10.1038/s41531-023-00525-w.
3
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results.
左旋多巴卡比多巴肠凝胶治疗晚期帕金森病:DUOGLOBE 最终 3 年结果。
J Parkinsons Dis. 2023;13(5):769-783. doi: 10.3233/JPD-225105.
4
Impact of advanced Parkinson's disease on caregivers: an international real-world study.晚期帕金森病对照料者的影响:一项国际真实世界研究。
J Neurol. 2023 Apr;270(4):2162-2173. doi: 10.1007/s00415-022-11546-5. Epub 2023 Jan 12.
5
Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies.新冠病毒与帕金森病:护理、疫苗接种及对先进疗法的影响。
Int Rev Neurobiol. 2022;165:173-196. doi: 10.1016/bs.irn.2022.04.005. Epub 2022 Jul 9.
6
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study.PEG-J 替换帕金森病患者十二指肠左旋多巴输注:回顾性研究。
BMC Neurol. 2022 Jan 13;22(1):25. doi: 10.1186/s12883-021-02546-5.
7
Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶用于晚期帕金森病的患者及照料者结局
NPJ Parkinsons Dis. 2021 Nov 30;7(1):108. doi: 10.1038/s41531-021-00246-y.
8
The Efficacy of Tai Chi and Stretching Exercises Based on a Smartphone Application for Patients With Parkinson's Disease: A Protocol for a Randomized Controlled Trial.基于智能手机应用程序的太极拳和伸展运动对帕金森病患者的疗效:一项随机对照试验方案
Front Neurol. 2021 Oct 28;12:731606. doi: 10.3389/fneur.2021.731606. eCollection 2021.
9
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.DUOGLOBE:左旋多巴卡比多巴肠凝胶治疗帕金森病的真实世界研究中的一年期结果
Mov Disord Clin Pract. 2021 Sep 12;8(7):1061-1074. doi: 10.1002/mdc3.13239. eCollection 2021 Oct.
10
Close relationships in Parkinson´s disease patients with device-aided therapy.帕金森病患者接受器械辅助治疗时的亲密关系。
Brain Behav. 2021 Jun;11(6):e02102. doi: 10.1002/brb3.2102. Epub 2021 May 5.